Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.
Clinical trial NCT07585526 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07585526
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2028-03-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.